Xcellerex, Inc. began construction of a cGMP FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA, with completion scheduled for September 2010. The facility expands capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities.The new facility will feature 2,000 liter Xcellerex XDR single-use bioreactors and modular single-use downstream unit operations through bulk-product. The plant will also support Xcellerex’s contract manufacturing operations.

Xcellerex founder and chief technology officer Parrish Galliher said, “This new FlexFactory facility in Marlborough will be a great case study, demonstrating the power of the FlexFactory capability. We will achieve new working capacity in less than six months, at a fraction of the cost required for a conventional facility. This will also give us a hands-on educational tool to help prospective customers achieve a deeper understanding of how a FlexFactory operates.”